To purchase hard copies of this book, please email:
orders@intechopen.com
By only printing on demand InTech ensures our carbon footprint is kept to a minimum.
The data below shows the environmental impact of printing one single book:
79.94 kg wood
4.3 g CO2
72.58 ml Water
Share this page
Huntington's Disease - Core Concepts and Current Advances
Edited by Nagehan Ersoy Tunali, ISBN 978-953-307-953-0, Hard cover, 554 pages, Publisher: InTech, Published: February 15, 2012 under CC BY 3.0 license, in subject Mental and Behavioural Disorders and Diseases of the Nervous System
DOI: 10.5772/1470
Huntington's Disease is one of the well-studied neurodegenerative conditions, a quite devastating and currently incurable one. It is a brain disorder that causes certain types of neurons to become damaged, causing various parts of the brain to deteriorate and lose their function. This results in uncontrolled movements, loss of intellectual capabilities and behavioural disturbances. Since the identification of the causative mutation, there have been many significant developments in understanding the cellular and molecular perturbations. This book, "Huntington's Disease - Core Concepts and Current Advances", was prepared to serve as a source of up-to-date information on a wide range of issues involved in Huntington's Disease. It will help the clinicians, health care providers, researchers, graduate students and life science readers to increase their understanding of the clinical correlates, genetic aspects, neuropathological findings, cellular and molecular events and potential therapeutic interventions involved in HD. The book not only serves reviewed fundamental information on the disease but also presents original research in several disciplines, which collectively provide comprehensive description of the key issues in the area.
This book is indexed in:
Book contents
- Chapter 1Huntington’s Disease: From the Physiological Function of Huntingtin to the Disease
- Chapter 2Modeling Huntington’s Disease: in vivo, in vitro, in silico
- Chapter 3Molecular Mechanism of Huntington’s Disease — A Computational Perspective
- Chapter 4Biomarkers for Huntington’s Disease
- Chapter 5Quinolinate Accumulation in the Brains of the Quinolinate Phosphoribosyltransferase (QPRT) Knockout Mice
- Chapter 6Alterations in Expression and Function of Phosphodiesterases in Huntington’s Disease
- Chapter 7Cognition in Huntington's Disease
- Chapter 8Early Dysfunction of Neural Transmission and Cognitive Processing in Huntington’s Disease
- Chapter 9Endogenous Attention in Normal Elderly, Presymptomatic Huntington’s Disease and Huntington’s Disease Subjects
- Chapter 10Computational Investigations of Cognitive Impairment in Huntington's Disease
- Chapter 11Targeting Transcriptional Dysregulation in Huntington’s Disease: Description of Therapeutic Approaches
- Chapter 12ZNF395 (HDBP2 /PBF) is a Target Gene of Hif-1α
- Chapter 13Role of Huntington’s Disease Protein in Post-Transcriptional Gene Regulatory Pathways
- Chapter 14Energy Metabolism in Huntington’s Disease
- Chapter 15The Use of the Mitochondrial Toxin 3-NP to Uncover Cellular Dysfunction in Huntington’s Disease
- Chapter 16Consequences of Mitochondrial Dysfunction in Huntington's Disease and Protection via Phosphorylation Pathways
- Chapter 17Cholesterol Metabolism in Huntington’s Disease
- Chapter 18Cellular Therapies for Huntington’s Disease
- Chapter 19Ameliorating Huntington's Disease by Targeting Huntingtin mRNA
- Chapter 20Don’t Take Away My P: Phosphatases as Therapeutic Targets in Huntington’s Disease
- Chapter 21BDNF in Huntington’s Disease: Role in Pathogenesis and Treatment
- Chapter 22Risk and Resilience: Living with a Neurological Condition with a Focus on Health Care Communications
- Chapter 23Communication Between Huntington’s Disease Patients, Their Support Persons and the Dental Hygienist Using Talking Mats
